SCHEMBL825447

SCHEMBL825447

CCCCCCc1ccccc1C(=O)OC(=O)c1cccc(N(CC)CC)c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BID P55957 3/20 0.42
MCL1 Q07820 3/20 0.42
PPARA Q07869 3/20 0.42
BCL2L1 Q07817 2/20 0.42
BAK1 Q16611 2/20 0.42
KAT8 Q9H7Z6 2/20 0.42
PPARG P37231 2/20 0.42
SAE1 Q9UBE0 2/20 0.42
EP300 Q09472 1/20 0.42
KAT2A Q92830 1/20 0.42
KAT2B Q92831 1/20 0.42
KAT5 Q92993 1/20 0.42
ALOX5 P09917 1/20 0.41
PTGS2 P35354 1/20 0.41
TSHR P16473 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
THRA P10827 1/20 0.39
THRB P10828 1/20 0.39
LIPG Q9Y5X9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17219520 0.91 BID (0.41) BIDMCL1PPARABCL2L1BAK1
SCHEMBL28962198 0.90 TSHR (0.43) BIDMCL1PPARABCL2L1BAK1
SCHEMBL27737799 0.87 BID (0.45) BIDMCL1PPARABCL2L1BAK1
SCHEMBL3290584 0.84 BID (0.48) BIDMCL1PPARABCL2L1BAK1
SCHEMBL30656414 0.82 TSHR (0.53) BIDMCL1PPARABCL2L1BAK1
SCHEMBL1712189 0.82 ALDH1A1 (0.50) BIDMCL1PPARABCL2L1BAK1
SCHEMBL570967 0.80 BID (0.54) BIDMCL1PPARABCL2L1BAK1
SCHEMBL27756068 0.80 MEN1 (0.51) BIDMCL1PPARABCL2L1BAK1
SCHEMBL2492662 0.79 TSHR (0.62) TSHRALDH1A1LMNATP53CYP3A4
SCHEMBL29054012 0.79 PLK1 (0.43) BIDMCL1PPARABCL2L1BAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 874 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260027022-A1 ENCAPSULATION COMPOSITIONS COMPRISING LIQUID CRYSTAL PARTICLES AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING THE SAME ELC MAN LLC (US) 2026-01-29 US claimed
WO-2025123103-A1 LIQUID BASE COMPOSITION WITH GLYCOLIC ACID FOR MOISTURISING AND REDUCING SUN SPOTS ON THE SKIN AND PROCESS FOR OBTAINING SAME BOTICA COMERCIAL FARMACÊUTICA LTDA. (BR) 2025-06-19 WO claimed
EP-4551182-A1 ENCAPSULATION COMPOSITIONS COMPRISING LIQUID CRYSTAL PARTICLES AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING THE SAME ELC Management LLC (US) 2025-05-14 EP claimed
CN-119700607-A Sun-screening composition and preparation method thereof 上海自然堂集团有限公司 2025-03-28 CN claimed
CN-117297983-B Organic sun-screening agent gel, preparation method thereof and cosmetics 广东丸美生物技术股份有限公司 2025-02-21 CN claimed
CN-119278025-A Sunscreen compositions comprising metal oxides, SPF active ingredients, and one or more SPF enhancing components including light stabilizers, antioxidants, or combinations thereof 高露洁-棕榄公司 2025-01-07 CN claimed
EP-3576847-B1 SUNSCREEN COMPOSITIONS WITH NATURAL WAXES FOR IMPROVED WATER RESISTANCE EDGEWELL PERSONAL CARE BRANDS LLC (US) 2024-07-03 EP claimed
WO-2024109387-A1 REFRESHING BROAD-SPECTRUM SUNSCREEN COMPOSITION HAVING HIGH UVA PROTECTION RATE 上海家化联合股份有限公司 2024-05-30 WO claimed
US-11986548-B2 Hydrophobic topical compositions and methods for producing same EDGEWELL PERSONAL CARE BRANDS, LLC (US) 2024-05-21 US claimed
WO-2024031316-A1 ENCAPSULATION COMPOSITIONS COMPRISING LIQUID CRYSTAL PARTICLES AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING THE SAME ELC MANAGEMENT LLC (US) 2024-02-15 WO claimed
US-8263050-B2 Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions HALLSTAR INNOVATIONS CORP. (US) 2012-09-11 US claimed
US-7713519-B2 Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions HALLSTAR INNOVATIONS CORP. (US) 2010-05-11 US claimed
US-20090291141-A1 METHOD OF QUENCHING ELECTRONIC EXCITATION OF CHROMOPHORE-CONTAINING ORGANIC MOLECULES IN PHOTOACTIVE COMPOSITIONS HALLSTAR INNOVATIONS CORP. (US) 2009-11-26 US claimed
US-20090246157-A1 METHOD OF QUENCHING ELECTRONIC EXCITATION OF CHROMOPHORE-CONTAINING ORGANIC MOLECULES IN PHOTOACTIVE COMPOSITIONS HALLSTAR INNOVATIONS CORP. (US) 2009-10-01 US claimed
US-20090208435-A1 METHOD OF QUENCHING ELECTRONIC EXCITATION OF CHROMOPHORE-CONTAINING ORGANIC MOLECULES IN PHOTOACTIVE COMPOSITIONS HALLSTAR INNOVATIONS CORP. (US) 2009-08-20 US claimed
US-20090074687-A1 METHOD OF QUENCHING ELECTRONIC EXCITATION OF CHROMOPHORE-CONTAINING ORGANIC MOLECULES IN PHOTOACTIVE COMPOSITIONS HALLSTAR INNOVATIONS CORP. (US) 2009-03-19 US claimed
EP-2025324-A1 Method of Quenching Electronic Excitation of Chromophore-Containing Organic Molecules in Photoactive Compositions HallStar Innovations Corp. (US) 2009-02-18 EP claimed
EP-2025323-A1 Method of Quenching Electronic Excitation of Chromophore-Containing Organic Molecules in Photoactive Compositions HallStar Innovations Corp. (US) 2009-02-18 EP claimed
WO-2009020675-A1 METHOD OF QUENCHING ELECTRONIC EXCITATION OF CHROMOPHORE-CONTAINING ORGANIC MOLECULES IN PHOTOACTIVE COMPOSITIONS HALLSTAR INNOVATIONS CORP. (US) 2009-02-12 WO claimed
EP-1859776-A2 Cosmetic sun protection agent Coty Prestige Lancaster Group GmbH (DE) 2007-11-28 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260027022-A1 ENCAPSULATION COMPOSITIONS COMPRISING LIQUID CRYSTAL PARTICLES AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING THE SAME MGLL, DAGLA, LIPG BID 1657/4885MCL1 2457/4885PPARA 276/4885
US-20090208435-A1 METHOD OF QUENCHING ELECTRONIC EXCITATION OF CHROMOPHORE-CONTAINING ORGANIC MOLECULES IN PHOTOACTIVE COMPOSITIONS C1S, CBR3, C9 BID 1869/4885MCL1 3842/4885PPARA 2877/4885
US-20090291141-A1 METHOD OF QUENCHING ELECTRONIC EXCITATION OF CHROMOPHORE-CONTAINING ORGANIC MOLECULES IN PHOTOACTIVE COMPOSITIONS C1S, CBR3, C9 BID 1833/4885MCL1 3800/4885PPARA 2620/4885
US-20090074687-A1 METHOD OF QUENCHING ELECTRONIC EXCITATION OF CHROMOPHORE-CONTAINING ORGANIC MOLECULES IN PHOTOACTIVE COMPOSITIONS CRYAA, CRY2, CRYAB BID 1363/4885MCL1 3700/4885PPARA 2777/4885
US-20090246157-A1 METHOD OF QUENCHING ELECTRONIC EXCITATION OF CHROMOPHORE-CONTAINING ORGANIC MOLECULES IN PHOTOACTIVE COMPOSITIONS C1S, CBR3, C9 BID 1833/4885MCL1 3800/4885PPARA 2620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.